The cardiac arrhythmia suppression trial.
Buss
J
J
Lasserre
J J
JJ
Heene
D L
DL
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D002121:Calcium Channel Blockers / Q000008:administration & dosage* / Q000009:adverse effects; D006323:Heart Arrest / Q000517:prevention & control; D006801:Humans; D012770:Shock, Cardiogenic / Q000517:prevention & control
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D002121:Calcium Channel Blockers